| Code | Description | Claims | Beneficiaries | Total Paid |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
10,616 |
10,266 |
$2.09M |
| H2035 |
Alcohol and/or other drug treatment program, per hour |
17,273 |
2,022 |
$1.77M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
4,583 |
4,387 |
$1.27M |
| H0001 |
Alcohol and/or drug assessment |
850 |
795 |
$145K |
| H2012 |
Behavioral health day treatment, per hour |
649 |
81 |
$88K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
106 |
97 |
$40K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
4,644 |
4,306 |
$39K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,053 |
941 |
$38K |
| 80053 |
Comprehensive metabolic panel |
1,602 |
1,456 |
$36K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
489 |
457 |
$36K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
598 |
574 |
$33K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,205 |
1,138 |
$23K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
185 |
183 |
$21K |
| 71046 |
Radiologic examination, chest; 2 views |
249 |
238 |
$12K |
| 85027 |
|
669 |
644 |
$11K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
124 |
121 |
$10K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
198 |
174 |
$8K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
101 |
90 |
$5K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
53 |
49 |
$2K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
62 |
24 |
$2K |
| 36415 |
Collection of venous blood by venipuncture |
1,739 |
1,591 |
$2K |
| 90834 |
Psychotherapy, 45 minutes with patient |
20 |
12 |
$2K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
566 |
513 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
333 |
173 |
$2K |
| 84484 |
|
174 |
141 |
$1K |
| J2704 |
Injection, propofol, 10 mg |
160 |
91 |
$905.44 |
| J7050 |
Infusion, normal saline solution, 250 cc |
451 |
141 |
$712.57 |
| G0500 |
Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) |
12 |
12 |
$652.93 |
| 83690 |
|
72 |
67 |
$628.90 |
| 81001 |
|
121 |
116 |
$627.82 |
| 36591 |
|
16 |
12 |
$473.84 |
| 86140 |
|
70 |
66 |
$389.79 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
81 |
77 |
$346.58 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
13 |
13 |
$328.10 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
14 |
14 |
$256.27 |
| 83605 |
|
45 |
38 |
$205.39 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
58 |
53 |
$105.10 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
41 |
37 |
$73.24 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
35 |
27 |
$57.43 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
12 |
12 |
$50.64 |
| 81025 |
|
16 |
15 |
$44.97 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
13 |
13 |
$27.59 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
12 |
12 |
$20.07 |
| 87081 |
|
12 |
12 |
$15.50 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
23 |
13 |
$11.23 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
15 |
13 |
$6.74 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
770 |
575 |
$0.00 |